Objectives: Antibiotics for acute respiratory illness (ARI) constitute most pediatric medication use and contribute to the emergence of antimicrobial resistance. We investigated antibiotic prescription risk factors for ARI in pediatric clinics and clinical follow-up in individuals prescribed and not prescribed antibiotics.
A ntibiotics are the most widely used medication group in the worldwide pediatric population, 1 and approximately threefourths of all outpatient antibiotic prescriptions to children are associated with acute respiratory illness (ARI). 2 As of 2011, more than 1 in 5 pediatric ambulatory visits resulted in an antibiotic prescription, resulting in nearly 50 million prescriptions written annually in the United States. 3 Widespread antibiotic use contributes to the problem of growing selection pressure for drug-resistant bacterial strains. 4, 5 Antibiotic resistance in the United States costs an estimated $20 billion/year in excess healthcare costs, $35 billion in other societal costs, and more than $8 million in labor productivity losses as a result of additional hospital days. [6] [7] [8] To combat these trends, numerous public campaigns have been launched during the past decade to promote judicious prescription practice. 6, 9, 10 Because prescriptions for ARI constitute most pediatric antibiotic use, it is particularly concerning that antibiotics have been prescribed routinely for conditions for which there are no clear benefits, specifically viral respiratory illnesses. 3, 11, 12 It is encouraging that outpatient antibiotic prescriptions for children have been on the decline, [13] [14] [15] a result in part of the reduction in visits for otitis media (OM). 16 Proposed causes for these trends, in addition to educational efforts, include the introduction of pneumococcal conjugate vaccines, provided routinely to infants and young children since 2000, 17 and seasonal influenza vaccine recommendations being expanded to include healthy children 18 ; however, misuse of broad-spectrum antibiotics is still of vital concern. 16, 19, 20 In addition to the public health implications, antibiotic use can lead to direct adverse outcomes, including diarrhea, allergic urticaria, dermatitis, and unintentional overdoses, for the children receiving them. [21] [22] [23] We evaluated children who presented to two academic outpatient facilities with ARI, with respect to their clinical diagnoses, socioeconomic factors, and medical history, to better understand the factors associated with antibiotic prescribing for these children. In addition, we assessed follow-up telephone calls and return visits in the 30 days after the initial visit for those who were and were not prescribed antibiotics.
Methods
Institutional review board approval from the Vanderbilt University human research protection program was obtained for both the parent surveillance study and for our chart review study. Datasets were stored in REDCap, 24 a secure and deidentified database supported by the academic institution.
Participant Enrollment
Participants in the study were children ages 2 to 17 years enrolled in an ongoing multicenter influenza surveillance study during the 2013-2014 influenza season. The participants presented to a pediatric clinic at one of two outpatient sites. Enrollment took place between December 2013 and April 2014 from 8 AM to 4 PM, Monday through Friday, and from 8 AM to 12 PM on Saturdays. Trained staff reviewed the appointment schedule to identify eligible participants, and the child and his or her parents/guardians were approached to provide informed consent and assent. Inclusion criteria included acute respiratory symptoms; oral temperature ≥100.0°F (37.8°C) at study visit, or history of fever reported by parents, or use of an antipyretic before study visit; symptom onset <5 days before study visit; and no receipt of an antiviral drug for influenza or influenza vaccination during the 14 days before enrollment.
Demographic and Clinical Information

Enrollment Visit
In the parent multicenter observational study, funded by MedImmune 25 and performed to assess influenza vaccine effectiveness, a standardized survey pertaining to the child's medical history, seasonal influenza vaccine status, social and economic background, and presenting symptoms was administered to the parent/guardian. Medical notes on the visit, including records of any laboratory tests performed, medications prescribed, and discharge diagnoses, were collected in a standardized format using a chart review of the electronic medical record system. Confirmatory influenza testing via reverse transcriptase polymerase chain reaction was completed after the visit in a research laboratory, and the results were not available to the providers at the time of the visit. A small number of providers ordered rapid influenza diagnostic tests in the clinics.
30-Day Follow-up
We collected additional data, which was confined to one academic institution in the same city with two outpatient clinics. A chart review for the 30-day period after the enrollment visit was conducted to evaluate how many times the participants called or made return visits for problems related to the original ARI or new ARI symptoms. Multiple telephone calls and visits were collapsed into their respective categories-in other words, we made no distinction between making one telephone call and, for example, three telephone calls in our analyses.
Telephone calls and return visits were documented as being the result either of continuing or new ARI symptoms or a possible medication reaction (eg, rash, diarrhea, difficulty breathing). We also documented whether the child was instructed to make a return visit, and if a return visit was made, the facility visited, medications prescribed, laboratory tests completed, and discharge diagnoses as noted in the clinical notes or discharge summary.
Two independent reviewers separately reviewed the charts of the entire participant pool of 206 children. Any discrepancies between the reviews were noted and reconciled between the reviewers after a second round of chart review together.
Statistical Analysis
Descriptive summaries of the participant population were performed. Pearson χ 2 or Wilcoxon rank sum test was used to compare groups with or without antibiotic prescriptions at the enrollment visit or patients with or without return visit in terms of demographic and clinical characteristics. A two-sided P < 0.05 indicated statistical significance. All of the analyses were completed using STATA/IC 13 (StataCorp, College Station, TX). Our study used data collected for the parent study. (Additional data collection and analysis for the substudy was not funded by MedImmune.)
Risk Factors for Antibiotic Prescription
To evaluate factors associated with receiving antibiotics at the enrollment visit, we used a multivariable logistic regression model. Because of potential diagnostic overlap, discharge diagnoses of viral illness, influenza, and other upper respiratory illness (URI) were combined into one category. Low count caused bronchiolitis/bronchitis (one participant), acute asthma exacerbation (two participants), and wheezing (one participant) to be combined into the category of lower respiratory tract illnesses. The diagnoses of allergic rhinitis, croup, tonsillitis, other respiratory tract illnesses, paroxysmal coughing, respiratory syncytial virus, and sinusitis were dropped from the regression model because none of the participants with these primary diagnoses were prescribed antibiotics. The diagnosis of cough was dropped because of low count. Other covariates entered into the regression model included clinic site, insurance type, race, influenza vaccination in the 2013-2014 flu season before enrollment visit, and chronic illnesses. A secondary logistic regression was performed in which the discharge diagnoses were grouped into either "probably appropriate" (streptococcal pharyngitis, acute OM [AOM], and pneumonia/pneumonitis, and sinusitis) or "probably inappropriate" (viral illness, influenza, URI, bronchiolitis, acute asthma exacerbation, wheezing, allergic rhinitis, cough, croup, tonsillitis, paroxysmal coughing, and respiratory syncytial virus). Pneumonia was diagnosed when a radiologistread chest radiography indicated pathologic findings. We relied on clinical diagnoses of sinusitis. The preliminary analysis did not show age to be an independent risk factor for antibiotic prescription and this variable was removed from the final model.
30-Day Follow-up
Descriptive summaries of follow-up calls and return visits were performed. The relation between having been prescribed antibiotics and follow-up/return visits was evaluated using bivariate analyses (Pearson χ 2 ). Participants who did and did not make return visits were characterized by age, sex, race/ethnicity, clinic site, insurance, chronic illnesses, and diagnosis at the initial visit. Logistic regressions on the risk factors for all and for AOM return visits were performed. The covariates in the models included clinic site, insurance type, race/ethnicity, and chronic illnesses.
Characteristics of all of the participants who did not receive antibiotics at the initial visit but returned to receive antibiotics at follow-up were described.
Results
There were 219 eligible children who were approached; 206 (94%) were consented and enrolled in the parent study. All of the children in the study received their primary care at the academic hospital. There were 130 (63%) children enrolled in pediatric on-campus clinics, which include continuity clinics for pediatric residents, and have a high proportion of children enrolled in Medicaid. There were 76 (37%) children enrolled at off-campus pediatric and adolescent clinics, which were staffed primarily by attending physicians with more privately insured patients. Descriptive summaries of the participant characteristics are presented in Table 1 ; 49% of the participants were male, 52% were non-Hispanic white, 39% were non-Hispanic African American, 6% were Latino, 4% were Asian, and 1% was other race. A total of 50% had public insurance, 47% had private insurance, and 3% had both types. Twenty-six percent of the children had one or more chronic illnesses. Seventy-four percent of the children received influenza vaccination during the 2013-2014 flu season. Seven children had a rapid influenza test completed in the clinic (three positive and four negative results). Of the three children testing positively, two were diagnosed as having influenza and one as having viral illness.
Race/ethnicity, clinic site, and insurance type were found to be significantly different between those prescribed and not prescribed antibiotics on bivariate analyses (Table 1) , but none were independently associated with antibiotic prescriptions in the multivariate analysis. Children who were prescribed antibiotics were less likely than those not prescribed to have reported headaches and vomiting. Having one or more chronic illnesses was not associated with differences in receiving antibiotics. The children who were prescribed antibiotics were less likely than those not prescribed to have been diagnosed as having influenza, URI, pharyngitis, and viral illness and more likely to have been diagnosed as having AOM, pneumonia/pneumonitis, and streptococcal pharyngitis. Lastly, no participant was prescribed both antivirals and antibiotics at this visit.
Fifty-nine (29%) children were prescribed oral antibiotics at their initial visit, 51 (86%) of these for indicated diagnoses: 34 for streptococcal pharyngitis, 15 for AOM, and 2 for pneumonia. Fourteen of 206 children (7%) were prescribed antiviral medications. Of the children who received antibiotics, 76% received penicillin, 12% azithromycin, 3% cephalosporins, 3% fluoroquinolones, 2% sulfa drugs, and 2% clindamycin. Nine (4%) additional children with pharyngitis at the initial visit and who had a negative streptococcal rapid antigen detection test (RADT) were prescribed antibiotics (100% penicillin) when their culture tested positive (counted as "pharyngitis/not prescribed antibiotics" in Table 1 ).
Risk Factors for Prescription of Antibiotics
Risk factors for being prescribed an antibiotic at the initial visit are presented in Table 2 . All 15 patients with a diagnosis of AOM and both children diagnosed with pneumonia were prescribed antibiotics. The only other factor that was independently associated with receiving antibiotics was a diagnosis of streptococcal pharyngitis. A secondary analysis using the classification of "probably appropriate" compared with the "probably not appropriate" grouping of the primary diagnosis demonstrated similar results; here, having an appropriate discharge diagnosis was the only factor independently associated with receiving an antibiotic (odds ratio 286.05, 95% confidence interval 71.13-1150.38). Further subset analyses separating those who were and were not diagnosed as having streptococcal pharyngitis did not identify significant risk factors for antibiotic prescription in either group. Additional analysis excluding the diagnosis of streptococcal pharyngitis as a covariate identified the diagnoses of URI and influenza/viral illness as independent negative predictors of receiving antibiotics.
Follow-up Patterns
The follow-up patterns of participants are described in the Figure. Of the 59 children who were prescribed antibiotics, 17% (n = 10) made follow-up telephone calls and 27% (n = 16) made at least one return visit. In comparison, of the 147 children who were not prescribed antibiotics, 17% (n = 25) made follow-up telephone calls and 17% (n = 25) made at least 1 return visit. Having an antibiotic prescribed at the enrollment visit was significantly associated with return clinic visits, and only 2 of 16 return visits were made to check for resolution of AOM. Two children (3%) who were prescribed antibiotics returned to the emergency department (ED); one with AOM returned with AOM and one with viral illness returned with vomiting. Nine children (6%) not prescribed antibiotics returned to the ED: two with pneumonia, one with AOM, one with streptococcal pharyngitis, three with viral syndrome, one with influenza, and one with continued ARI symptoms and diabetic ketoacidosis was subsequently hospitalized. Adverse gastrointestinal effects were reported in 4 of 59 (7%) children prescribed antibiotics (3 telephone calls, 1 return visit) and 1 of 14 (7%) children prescribed oseltamivir (1 telephone call and 1 return visit).
Of the children who received an antibiotic prescription at the initial visit, 7 (12%) were prescribed another antibiotic at the return visit, including 3 children with AOM at both the initial and return visits (one of whom later developed Clostridium difficile colitis); 3 children with streptococcal pharyngitis, and 1 child with wheezing/possible pneumonia. Of the 147 children who were not prescribed antibiotics at the initial visit, 9 (6%) with pharyngitis were prescribed an antibiotic when their cultures tested positive for group A streptococcus, and an additional 9 (6%) received antibiotics during a return visit. The nine children who were prescribed antibiotics after a positive culture were counted as having received antibiotics previously in the follow-up analyses. These nine children made return visits within a median of 9 days (interquartile range 5-15). Eight (89%) of these children were originally diagnosed as having URI or viral illness. Two children were diagnosed as having pneumonia at 3 and 4 days after the initial visit. Two children were diagnosed as having streptococcal pharyngitis at 14 and 15 days, 2 with AOM at 8 and 29 days, and 1 each with sinusitis and bacterial conjunctivitis. One child was diagnosed as having allergic rhinitis, returned in 5 days, and was diagnosed as having viral illness and was prescribed antibiotics. The characteristics of the children who did and did not make return visits are summarized in Table 3 . Of the 206 children, 41 (20%) returned to the clinic or ED within 30 days of the initial visit. A greater proportion of the children who returned were non-Hispanic white, seen at the off-campus clinic, had private insurance, and were diagnosed as having AOM at the initial visit. Of the 41 children who made return visits, 7 (17%) were diagnosed as having viral illness; 7 (17%) as having URI; 7 (17%) as having streptococcal pharyngitis; 5 (12%) as having AOM; 2 (5%) as having pneumonia; 6 (15%) collectively as having acute asthma exacerbation, conjunctivitis, or vomiting; and 24 (59%) as having other diagnoses. Note that one child may have more than one diagnosis associated with a return visit. Fifteen (37%) of the children who returned were diagnosed as having streptococcal pharyngitis or AOM at the initial visit and had already been treated with antibiotics. We were unable to identify factors associated with return visits.
Discussion
Physicians in our study rarely prescribed antibiotics for diagnoses of low clinical indication (eg, nonspecific URIs, viral illnesses, influenza). Eighty-six percent (n = 51) of children prescribed an antibiotic had a diagnosis of streptococcal pharyngitis, AOM, or pneumonia/pneumonitis. In the univariate analyses children who were non-Hispanic white or Asian, who had private insurance, and who were examined at the off-campus clinic site were likely to be prescribed antibiotics. These factors were no longer statistically significant in the multivariate analysis, however, suggesting that some of the differences were explained by differences in discharge diagnoses. Only 1 of 24 children diagnosed as having viral illness and 2 of 64 children diagnosed as having URI received antibiotics.
All of the children in the study diagnosed as having AOM received antibiotics at the enrollment visit. For children younger than 2 years, there is good evidence that antibiotics (specifically, amoxicillin clavulanate) help to reduce the time to resolution of symptoms and overall symptom burden in AOM. 26 In older children, however, the benefits of antibiotic treatment for AOM are less clear. [27] [28] [29] In children 2 years or older with nonsevere unilateral AOM, the American Academy of Pediatrics guidelines offer the grade B recommendation to either prescribe antibiotic therapy or observe with plans for close follow-up; specifically: "a mechanism must be in place to ensure follow-up and begin antibiotic therapy if the child worsens or fails to improve within 48 to 72 hours of onset of symptoms." 28 In our study, none of the clinicians chose to use the "watchful waiting" strategy recommended by these guidelines. The desire to reduce follow-up visits, patient volume, legal concerns, 30 and constraints of daily practice 31 has been found to influence physicians' antibiotics prescribing behavior. It is noteworthy that of the 15 children in our study who were prescribed antibiotics for AOM, 40% (n = 6) made return visit within 30 days.
A high proportion of antibiotic use in our population was for streptococcal pharyngitis. There were 65 and 10 children diagnosed as having pharyngitis at initial and follow-up visits, respectively. Of these, 72% (n = 47) of the initial cases and 70% (n = 7) of the follow-up cases tested positive for group A streptococci (GAS) via RADT or follow-up culture. GAS pharyngitis generally accounts for 20% to 30% of cases of pharyngitis in children. 32 Our study aimed to enroll only children with a history of fever, which may account in part for the higher than expected prevalence of GAS detections. The RADT is highly specific for GAS; a positive test can be considered equivalent to a positive throat culture and antibiotic therapy initiated without further microbiologic confirmation. 33 The threshold for treating with antibiotics is typically low once the diagnosis of GAS pharyngitis is established because of their important preventive role in the development of acute rheumatic fever and suppurative complications. Based on the Modified Centor Score, 34 febrile children 3 to 14 years old (score of 2) should receive antibiotics if the throat culture or RADT is positive; however, RADT does not effectively differentiate acutely infected patients from asymptomatic chronic carriers. 33 As such, it is possible that some of the children with positive RADT were GAS carriers with a different concurrent ARI instead of overt acute GAS pharyngitis.
It also is possible that antibiotics could prevent complications from ARIs. In a large-scale retrospective cohort study, Petersen et al 35 found that serious complications (defined as mastoiditis after AOM, peritonsillar abscess after sore throat, and pneumonia after URI) were rare and that the number needed to treat with antibiotics to prevent these complications was large; the exception was in patients with chest infections, for whom the risk of pneumonia is relatively high. 35 Our study was not designed to evaluate the benefit of prophylactic antibiotics. Two children who did not receive antibiotics at the initial visit returned within 5 days with pneumonia, and two children who did not receive antibiotics at the initial visit returned at 7 and 29 days and were diagnosed as having AOM. Overall, the number of return visits and the need for subsequent antibiotics were low in those not initially treated, and it is uncertain whether the subsequent visits for pneumonia or AOM could have been prevented had the children been given antibiotics at the initial visit.
It is unclear why a higher proportion of children who were prescribed antibiotics made return clinic visits. In a previous study, it was reported that children who were prescribed antibiotics for a respiratory illness returned almost twice as often for a second unplanned visit, 36 and that such prescribing behavior may in fact encourage clinic visits for subsequent episodes, 37 intensify pressure on clinicians to prescribe, 38 and increase overall antibiotic usage. It is unclear whether the increase in return visits in our study was the result of the prescription of antibiotics, differences in the underlying ARIs, or in characteristics of the children and/or their caregivers. Of the 41 children who made return visits, 15% (n = 6) were diagnosed as having AOM or pneumonia.
Our study has several important limitations. First, although our dataset contains a rich variety of participant characteristics and medical/laboratory findings, the study was not powered to show statistical significance in many of the findings. Second, our study was built within an influenza surveillance study; it is possible that providers altered their behavior based on the knowledge that their prescribing patterns would be monitored and preferentially chose diagnoses to justify antibiotic use. This use of diagnosis to justify antibiotic usage would overestimate the appropriate use of antibiotics. Lastly, this study may not be generalizable for the following reasons: this is an observational study in one academic setting, our study population does not include children younger than 2 years, we did not capture children with afebrile ARIs, physician diagnoses were not standardized or validated across providers, and we did not capture children who may have sought follow-up care in other healthcare systems.
Our findings indicate that the clinical practice of prescribing antibiotics for pediatric ARI within our study population was usually appropriate. To further reduce overall antibiotic use, interventions will need to be directed at diagnoses for which the majority of the antibiotics were prescribed-streptococcal pharyngitis and AOM. For streptococcal pharyngitis, the ability to identify carriage compared with infection and/or to identify infections unlikely to result in complications could limit antibiotic use for this indication. For AOM, declines in antibiotic use will require greater use of watchful waiting, increased routine vaccination against respiratory pathogens such as pneumococcus and influenza, and/or development of new vaccines for other pathogens that result in AOM. In general, the establishment of clinical practice guidelines and antibiotic stewardship programs with regular provider feedback also may improve antibiotic prescribing.
